服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-CD33 [SGN-33 (Lintuzumab)] (MABL-3684) | MABL-3684 | functional | Engineer antibody |
| Anti-CD4 [MT310] (MABL-3686) | MABL-3686 | Blocking, IHC-P, inhibition, IP, FC, IF | Engineer antibody |
| Anti-CD4 [YNB46.1.8 (Campath-9H)] (MABL-3687) | MABL-3687 | FC, IHC, IHC-Fr | Engineer antibody |
| Anti-CD40L [hu5c8 (Ruplizumab)] (MABL-3688) | MABL-3688 | WB, Block, FC | Engineer antibody |
| Anti-CD41 [7E3 (Abciximab)] (MABL-3689) | MABL-3689 | Block, FC | Engineer antibody |
| Anti-CD49B [GBR500 (Vatelizumab, TMC-2206)] (MABL-3690) | MABL-3690 | therapeutic, Block, ELISA, FC | Engineer antibody |
| Anti-CD52 [Alemtuzumab (Campath-1H)] (MABL-3691) | MABL-3691 | Cytotoxicity Assay, IHC-P, in vivo, WB, ELISA, FC, IHC-Fr | Engineer antibody |
| Anti-CD80 [IDEC-114 (Galiximab)] (MABL-3693) | MABL-3693 | IP, modulate, WB, Block, ELISA, FC, IHC | Engineer antibody |
| Anti-CD52 [YTH 34.5-G2b (Campath-1G)] (MABL-3692) | MABL-3692 | Cytotoxicity Assay, IHC-P, in vivo, WB, ELISA, FC, IHC-Fr | Engineer antibody |
| Anti-CCR2 [MLN1202 (Plozalizumab, hu1D9)] (MABL-3673) | MABL-3673 | therapeutic, Block, FC | Engineer antibody |
| Anti-CCR4 [KW-0761 (Mogamulizumab)] (MABL-3674) | MABL-3674 | deplete | Engineer antibody |
| Anti-IL-2R alpha [Basiliximab] (MABL-3708) | MABL-3708 | WB, Block, FC, IF, IHC | Engineer antibody |
| Anti-IL-5 [SB-240563 (Mepolizumab)] (MABL-3709) | MABL-3709 | therapeutic | Engineer antibody |
| Anti-IL-2R [Daclizumab] (MABL-3707) | MABL-3707 | Block, FC | Engineer antibody |
| Anti-IL-20 [h15D2 (Fletikumab)] (MABL-3706) | MABL-3706 | inhibit, neutralize, therapeutic, WB, ELISA | Engineer antibody |
| Anti-IL-12/23 [ABT-874 (Briakinumab)] (MABL-3705) | MABL-3705 | Block | Engineer antibody |
| Anti-FOLR1 [Farletuzumab (MORAb-003; M3)] (MABL-3703) | MABL-3703 | antagonist, functional assay, in vivo, inhibition, neutralizing, ELISA, IHC | Engineer antibody |
| Anti-IgE [huMaE11 (Omalizumab)] (MABL-3704) | MABL-3704 | crystallization, Block, ELISA | Engineer antibody |
| Anti-IL-5 [Sch 55700 (Reslizumab)] (MABL-3710) | MABL-3710 | inhibit, neutralize, therapeutic, Block | Engineer antibody |
| Anti-IL-6 receptor [rhPM-1 (Tocilizumab)] (MABL-3711) | MABL-3711 | inhibit, ELISA | Engineer antibody |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn